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Summary 
Article History 
 
India is known to have over 700 scheduled tribes which are native to five different regions 
viz., Himalayan, Central, Western, Dravidian and islands, each having its own primitive trait 
and cultural distinction. Out of these diverse territories, Central Indian region has the 
distinction of hosting 55% of the total tribal population of India which provides diverse region 
for bioprospecting. This region provides a natural, invaluable store house of indigenous 
medicinal plant diversity that is of great importance for mankind. Protection of traditional 
knowledge of these tribal communities residing in central India is the need of hour as 
overexploitation of natural resources due to increase in population may lead to extinction of 
important medicinal plant species. With careful management of the natural resources a 
sustainable balance can be achieved. The review envisages providing baseline data on 
important tribal communities and their status, traditional knowledge, medicinal properties of 
native plants of tribals and gives an insight for exploitation of these plants by pharmaceutical 
industry as well as insilico approach for screening new active compounds and drug 
designing. 
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Introduction 
Tribals are the native inhabitants of a geographically 
isolated region living close to nature. They are economically 
backward and culturally isolated and cater their basic 
necessities from the forests. They have distinct religious 
practices and cultural belief systems that demonstrate an 
immense knowledge and regulate the use of natural resources. 
According to 2001 census, India is known to have over 700 
scheduled tribes (STs), each having its own primitive trait and 
cultural distinction [1]. Tribals in India live in the following five 
territories: (i) The Himalayan belt: (Assam, Meghalaya, 
Arunachal Pradesh, Nagaland, Manipur, Mizoram, Tripura, hills 
of Uttar Pradesh and Himachal Pradesh) (ii) Central India: 
Bihar, West Bengal, Orissa, and Madhya Pradesh (iii) Western 
India: Rajasthan, Maharashtra, Gujarat, Goa, Dadra and Nagar 
Haveli. (iv) The Dravidian region: Karnataka, Andhra Pradesh, 
Kerala and Tamil Nadu. (v) Andaman, Nicobar and 
Lakshadweep islands [2]. 55% of the total tribal population of 
India lives in Central region. Certain primitive tribal region of 
central India are still beyond reach providing undisturbed 
natural niches where tapping of various medicinal plants can 
offer new insights for development of natural products. In India, 
about 95% of medicinal plants are obtained from wild sources 
and only 150 species are commercially utilized [3]. The 
indigenous knowledge of the tribal people of these medicinal 
plants are only identified, catalogued and documented, ie., only 
ethnobotanical studies are carried out for tribal regions. 
Medicinal plants are now being used as an alternative source 
to derive new antimicrobial compounds. The bioactive 
constituents of these medicinal plants that are of chemical 
nature can be studied and the chemical structure of a these 
bioactive compound and its biological properties can help in 
rational drug design. Different computational approaches have 
enhanced our understanding of interaction between proteins 
and chemical compounds which has facilitated the 
development of drug design [5]. Hence, the present review 
aims to discuss about various tribal communities of Central 
India, its status, their traditional knowledge, important novel 
medicinal plants of tribal region and their uses by validation of 
its pharmacological effects to produce novel drug entities. 
Demographic Status of Tribals in India 
According to the 1991 census, the population of STs in 
the country was 67.8 million constituting around 8% of the total 
population, whereas according to 2001 census the population 
of schedule tribes in the country was 84.3 million constituting 
around 8.2% of the total population. Decadal growth of 24.45 
% of tribal population had been observed.
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Figure 1: Tribals residing in five territories of India 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: ST Population with respect to Total Population according to 1991 and 2001 Consensus  
 
Status of Tribals in Central India 
Largest tribes are found in central region belt, over half 
the tribal population is concentrated in five states shown in 
table 1. In the year 1991, Madhya Pradesh accounted for 23% 
and Bihar 9.7% of the total tribal population in the country but 
in the year 2001 Madhya Pradesh along with Chhattisgarh 
accounts for 22.36% and Bihar along with Jharkhand 9.3% of 
the total tribal population in the country.
 
Table 1. ST Population in Different States of Central India 
ST Population in different states of Central India 1991 2001 
Madhya Pradesh (Madhya Pradesh + Chhattisgarh) 15.4 million 18.8 million 
Bihar (Bihar + Jharkhand) 6.6 million 7.8 million 
Orissa 7.0 million 8.1 million 
Andhra Pradesh 4.2 million 5.0 million 
West Bengal 3.8 million 4.4 million 
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The sex ratio among Scheduled Tribes is more favorable 
than general population, at 977 females per thousand males. 
Literacy rate has also increased from 8.53 percent in 1961 to 
47.10 percent in 2001 for STs while the corresponding 
increase for total population was from 28.30 percent in 1961 to 
64.84 percent in 2001, a significant increase in STs literacy 
rate can be observed. According to the 2001 Census figures, 
44.70% of the ST population were cultivators, 36.9% 
agricultural laborers, 2.1% house hold industry workers and 
16.3% were other occupation workers.  
However there are still some tribals residing in about 2,474 
identified forest villages in 12 States whose level of development 
is not at par with rest of the tribal villages. These states include 
Madhya Pradesh, Chhattisgarh, Jharkhand and Orissa of 
Central India consisting of 1362 forest villages. These also 
include particularly vulnerable tribal groups or primitive tribal 
groups characterized by a low rate of growth of population, pre-
agricultural level of technology and extremely low level of literacy 
[1]. These communities are declining or stagnant and are 
economically backward and 75 such groups are recognized. List 
of primitive tribal of Central India is given in Table 2.
 
 
Table 2: Primitive Tribal Groups of Central India 
State Primitive Tribal Communities 
A. Andhra Pradesh 
 
Bodo Gadaba 
Bondo Poroja 
Chenchu 
Dongria Khond 
Gutob Gadaba 
Khond Poroja 
Kolam 
Kondareddi 
Konda Savaras 
Kutia Khond 
Parengi Poroja 
 Thoti 
B. Bihar (including Jharkhand)   Asurs 
Birhor 
Birjia 
Hill Kharia 
Korwas 
Mal Paharia 
Parhaiyas 
Sauria Paharia 
Savar 
C. Madhya Pradesh (including Chhattisgarh)   
 
 Abujh Marias 
 Baigas 
 Bharias 
 Hill Korbas 
 Kamars 
 Saharias 
 Birhor 
D. Orissa Birhor 
Bondo 
Didayi 
Dongria-Khond 
Juangs 
Kharias 
Kutia Kondh 
Lanjia Sauras 
Lodhas 
Mankidias 
Paudi Bhuyans 
Soura 
Chuktia Bhunjia 
E. West Bengal Birhor 
Lodhas 
Totos 
 
The Ministry of Tribal Affairs was constituted in October 
1999 with the objective of providing more focused attention on 
the integrated socio-economic development of the most under-
privileged sections of the Indian society, the Scheduled Tribes 
(STs), in a coordinated and planned manner [1]. The tribal 
majority areas, which overlap with the country's major forest 
areas, are also areas with the highest concentrations of 
poverty [6]. The most common diseases among tribal 
communities are parasitic infections, diarrhoea, dysentery, skin 
diseases, respiratory infections, whooping cough and measles. 
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Serious diseases such as tuberculosis, leprosy and malaria are 
also common [6].  
Traditional Knowledge 
Primitive forest dwellers with good forest cover, rely on 
their traditional herbal medicine practices and indigenous 
knowledge. Indigenous Knowledge (IK) can be broadly defined 
as the knowledge that an indigenous (local) community 
accumulates over generations of living in a particular 
environment. This definition encompasses all forms of 
knowledge – technologies, know-how skills, practices and 
beliefs – that enable the community to achieve stable 
livelihoods in their environment [2]. The term ‘traditional 
knowledge’ has been defined by the World Intellectual Property 
Office Inter- Governmental Committee (WIPO- IGC) as 
including ‘indigenous knowledge relating to categories such as 
agricultural knowledge, medicinal knowledge, biodiversity-
related knowledge, and expressions of folklore in the form of 
music, dance, song, handicraft, designs, stories and artwork 
which have generally been transmitted from generation to 
generation; are generally regarded as pertaining to particular 
people or their territory; and are constantly evolving in 
response to a changing environment [8, 9]. Traditional 
knowledge of the tribals is based on years of experience and 
provides guidance and solution for not only sustainable 
environment but also use of medicinal plants for the treatment 
of various diseases. According to the World Health 
Organization more than 80% of the world's population relies on 
traditional medicine for their primary healthcare needs [10, 11]. 
India is rich in medicinal plant diversity. All known types of 
agro-climatic, ecologic and edaphic conditions are met within 
India [12, 13]. India is rich in all three levels of biodiversity, as 
species diversity, genetic diversity and habitat diversity [12, 
13]. These conditions enables the growth of almost 20,000 
plant species, of which 2,500 are of medicinal value [14]. 
Humans largely depend on less than 9000 plant species for 
food, clothing, shelter, medicines, forages and industry, and 
around 1,200 herbal plants are mentioned in ancient Indian 
texts.[15, 16] Of these, about 900 species have been 
domesticated for agriculture and from these about 168 species 
are specifically cultivated for food and agriculture [17]. The 
indigenous knowledge is not only confine to its use and 
collection but also about their specific characteristics (toxicity 
palatability), their spatial distribution, seasonal availability and 
ecological relationship etc. [17]. Through indiscriminate 
exploitation, destruction of habitats a number of medicinal 
legumes have already disappeared while others await a similar 
fate, at times even without our being aware of their existence. 
The excessive exploitation from the nature has resulted in 
shrinkage of these plant species, while few are facing the 
threat of extinction. Their regeneration, protection and 
preservation in nature are a challenge today to restore our 
biological heritage [18]. Still the conservation and protection of 
these wildly growing medicinal legumes of tribal region has 
been overlooked. The Botanical Survey of India (established in 
1890) and the Zoological Survey of India (established in 1916) 
are primarily responsible for survey of flora and fauna [16]. As 
suggested by Mairh et al, proper documentation of traditional 
ethnobotanical knowledge has not been done properly and the 
present era of globalization, traditional ethnobotanical 
information of the tribe is at stake of bio-piracy [17]. The most 
complex set of problems facing the future of traditional 
knowledge comes from the misappropriation of this knowledge 
from the local communities and tribal people who should be its 
rightful owners [16, 19]. Venkateraman in his review suggested 
that introduction of modern technologies and industrialization 
has lead to a gradual decline in these traditional knowledge, 
with  key component being  the introduction of intellectual 
property right (IPR) which was meant to protect innovators  for 
novel  product. However after being extended to the biological 
resources it does not provide protection for the traditional 
knowledge of the communities [16, 20]. The TRIPS Agreement 
also does not provide any specific mention about the traditional 
knowledge and innovations which are in the public domain. 
The grant of patents on non-original innovations (particularly, 
those linked to traditional medicines), which are based on what 
is already a part of the traditional knowledge of most of the 
developing and mega-biodiverse countries without their 
consent have been causing a great concern [16, 21]. 
Traditional knowledge is one of the most important source for 
sustainable development of developing countries in various 
fields like agriculture, food and medicine where biological 
resources are the main components. A wide array of natural 
products from botanicals are traditionally in use over several 
years [22]. According to World Health Organisation (WHO, 
2000), medicinal plants would be the best source to obtain a 
variety of drugs and hence its important to study their 
properties, safety and efficacy [11, 23]. Government of Tribal 
Affairs has set up Multi-State Cooperative Society in 1987 
under the Multi State Cooperative Societies Act, 1984 (now the 
Multi State Cooperative Societies Act, 2002) known as The 
Tribal Cooperative Marketing Development Federation of India 
Limited (TRIFED). TRIFED is now functioning both as a 
service provider and market developer for tribal products and it 
also looks after Research & Development / Intellectual 
Property Rights (IPR) of traditional knowledge. 
Ethnobotanical Studies of Medicinal Plants of Tribals from 
Central India 
Primitive tribals still residing in dense forest which are 
inaccessible and still not surveyed are     expected to be rich 
repositories of endemic and other species [16]. Medicinal 
Plants are studied from these tribal region in more intensified 
way to promote the proper uses of herbal medicines and to 
determine their potential as source of new drugs, which have 
folklore reputation [24-28]. 
Ethnobotanical study attempts to underline intimate 
relationship between plants and ethnic tribes [17, 29]. There is 
a rich local ethnobotanical knowledge and bibliography 
describing the species most frequently used by population to 
cure various diseases [29]. It is also not associated with many 
side effects and have an enormous therapeutic potential to 
heal many infectious diseases [30, 31].  
Many researchers have reported different medicinal 
plants from various regions which are being used by tribal 
communities for various therapeutic purposes. Ethnobotanical 
studies carried out on Birhore tribes of Bihar have reported 
varied plant species used by them depending on their day to 
day need. The description includes plant names, local name, 
family and usage [17]. Similarly documentation of 500 
medicinal plant species from Gond and Bharias of Madhya 
pradesh have been carried out by Acharya and Rai [43]. 
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Studies on khamptis tribe of Arunachal Pradesh recorded 37 
plant species of ethnomedicinal value belonging to 29 families. 
However researchers have only provided information of 
various plants found in different regions without confirming its 
medicinal activities, hence there is no scientific basis of use of 
traditional and herbal medicines [15].  
Antimicrobial Activity of Medicinal Plants 
Many researchers have reported antimicrobial activity of 
various medicinal plants from various regions which is now 
being used as an alternative source for drugs. Bioactive 
compounds are normally accumulated as secondary 
metabolites in all plant cells but their concentration varies 
according to the plant parts, season, climate and particular 
growth phase. Leaf is one of the highest accumulatory plant 
parts of such compounds and people are generally preferred it 
for therapeutic purposes. Some of the active compounds inhibit 
the growth of disease causing microbes either singly or in 
combination [32]. They can inhibit the growth of microbes by 
binding their surface proteins, breaking the peptide bonds, 
acting as chelating agents, altering their biochemical 
systematics or by preventing utilization of available nutrients to 
the microorganisms. Some compounds also cause lyses of 
microbial cells [32]. In studies carried out by Sharma et al it is 
observed that plant produce a wide variety of secondary 
metabolites which are used either directly as precursors or as 
lead compounds in the pharmaceutical industry and it is 
expected that plant extracts showing target sites other than 
those used by antibiotics will be active against drug resistant 
microbial pathogens [33]. Though the screening of Indian 
medicinal plants has revealed varying degrees of antimicrobial 
activity against pathogenic microorganisms but due to lack of 
experimental scientific studies, confirmation of the antimicrobial 
properties of a great number of these  remedies is not possible 
[33, 34].  
The most important bioactive constituents of plants are 
alkaloids, tannin, flavonoid and phenolic compounds [35]. 
Various industries are now looking into sources of alternative, 
more natural and environmentally friendly antimicrobials, 
antibiotics, antioxidants and crop protection agents hence 
various plant species are being investigated in detail and are 
being thoroughly tested for their pharmacological properties 
They are mainly interested in the discovery of active chemical 
structures from which they can develop and prepare synthetic 
analogues which are more controllable from the point of 
reproducibility, patentability, safety, and are more economically 
viable [36]. Some researchers have observed that volatile oils 
of many plants are known to have antimicrobial activity [37]. 
Plant essential oils also act as antioxidants which have been 
researched in detail with the view to investigate their protective 
role for highly unsaturated lipids in animal tissues [38]. The 
multidrug resistant strain of many microorganisms has 
revealed exploration of alternative antimicrobial agent.  As 
reported by Bhaskarwar et al Jatropha podagrica of family 
Euphorbiaceae is known for many biological activities such as 
antitumour, antimicrobial, molluscicidal and anti-insect [39- 41]. 
This plant is also used as an antipyretic, diuretic, choleretic 
and purgative [39]. Hundreds of new natural substances which 
are being isolated and identified every year are effective 
antimicrobial substances against a wide array of 
microorganisms, but data concerning their biological activities 
are known for only some [36]. Medicinal plants have become 
the focus of intense study in terms of validation of their 
traditional uses through the determination of their actual 
pharmacological effects [39]. This can be brought about by 
using different computational approaches for identifying 
promising lead candidates for the development and study of 
the bioactive substances of medicinal plants. 
Insilico Approach 
The pace of new discoveries, drug and vaccine design 
and the design of anti-microbial agents have been enhanced 
with the advent of various bioinformatics tools and techniques. 
It has made data analysis time and cost effective which was 
earlier unmanageable due to vast amount [42]. Various 
bioinformatics techniques and tools have been developed to 
identify and analyze  metabolic and regulatory pathways of 
cells in the last decade.  With the help of various bioinformatics 
techniques identification and analysis of various components of 
cells such as gene and protein function has become effortless. 
Using the combination of bioinformatics, wet lab, and cell 
simulation techniques, understanding of cellular mechanism 
and cellular manipulation will be less strenuous [43-45]. 
Bioinformatics has enabled in-silico associated molecular tools 
aiming to screen and identify genes coding for antimicrobial 
peptides from various cultivated or wild plants [46, 47]. Many 
researchers have reported that bioinformatics analysis will 
facilitate and quicken the analysis of systemic level behavior of 
cellular processes. It can be used for the microbial 
biotechnology in many ways:(i) the wet-lab data can be easily 
analyzed by computational approaches, (ii) genome 
sequencing, (iii) identification of protein coding segments and 
genome comparison to identify the gene function (iv) the 
development of genomic and  proteomics databases and (v) 
inference of phenotypes (higher level functions) from 
genotypes (gene level functions) [45, 51-61, 66]. 
Various researchers have undertaken some important 
studies to understand higher level cellular functions which 
include study of protein-protein and protein-DNA interactions to 
understand regulatory pathways. Studies are also carried out 
on automated reconstruction and comparison of metabolic 
pathways. Lots of research is being carried out on modeling 2D 
and 3D structure of proteins as well as modeling the docking of 
3D models of proteins with drugs for development of drug 
design [63]. Studies on interactions between chemical 
compounds and proteins has already enabled the development 
of drug design [63-66]. 
Approaches that are being used in bioinformatics are (i) 
use of computational search and alignment techniques to 
compare new genome against the set of known genes to 
annotate the structure and function of genes in a newly 
sequence genome, (ii) the use of mathematical modeling 
techniques such as data mining, statistical analysis, neural 
networks, genetic algorithm, and graph matching techniques to 
identify common patterns, features and high level functions, 
and (iii) an integrated approach that integrates search 
techniques with mathematical modeling [67, 68]. 
3D structure modeling and docking 
Antimicrobial drug researches rely on databases and 
chemo and bioinformatics tools that contain genomic, 
proteomic and functional information. The combination of 
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chemoinformatics tools, bioinformatics tools and relational 
databases provides means of analyzing, linking and comparing 
online search results [69]. A protein is known to exist under 
one or more low free-energy conformational states depending 
upon its interaction with other proteins. Under a stable 
conformational state certain regions of the protein are exposed 
for protein-protein or protein-DNA interactions. Function of a 
protein is dependent upon exposed active sites and hence it 
can be predicted by matching the 3D structure of an unknown 
protein with the 3D structure of a known protein [42, 57, 66]. 
3D structures of various proteins have been identified and 
submitted to databases with the help of X-ray crystallography 
and NMR spectroscopy but information is still limited hence 
alternate mechanism is required to relate a gene, its function 
and its 3D structure. Sequences matching is sufficient for 
function annotation but many times multiple sequences map to 
the same 3D structure and in such cases 2D structure 
matching can help to verify the function of newly sequenced 
protein [57, 71].  
Two major approaches to model 3D structure of a protein 
suggested are: (i) sequence homology based prediction and (ii) 
ab initio (or de novo) method. The sequence homology 
approach uses sequence alignment to identify the best 
matching 3D structure for different components: conserved 
portion, loop portion and side chains from the database, and 
threads them to predict the overall 3D structure. The ab initio 
method is based upon energy minimization principle, and 
predicts the structure from the sequence alone [66]. Docking is 
a term used to identify best matches between 3D structures of 
two molecules (receptor and ligand) that bind to each other by 
simulating interacting surfaces and free energy minimization at 
the domain level [63]. Docking problem requires modeling of 
surfaces using spheres (or grids) and identifying the best 
match that will fit two surfaces without excessive intersection. 
Many times biochemical information such as binding sites is 
provided. There are three major problems in docking: (i) for 
multidomain proteins conformation may change during 
docking, (ii) docking algorithms have high computational 
overhead that makes large-scale modeling quite slow, and (iii) 
docking algorithms suffer from over prediction that results in a 
high number of false positives [72]. As suggested by Bansal in 
his review the mathematical modeling approaches are suitable 
for new discoveries to derive candidate genes for vaccine and 
rational drug design, metabolic pathways, metabolic pathway 
variations, and transcription factors for regulatory pathways 
[73]. Most researchers have emphasized that bioinformatics 
techniques are critically dependent upon the knowledge 
derived from wet laboratories and the available computational 
algorithms and tools [4].  The validation of the results had to 
done by wet lab experiments as they are known to contain 
false positive and false negative. One of the methodology 
which allow cost saving, by reducing the required laboratory 
resources and time, for designing new drugs with specific 
biological activity is Quantitative structure activity relationships 
(QSAR). It establishes a correlation between trends in 
chemical structure modification and respective changes of 
biological activity [72,73]. There are various methods for using 
available evolutionary and structure-activity information to find 
new drug entities with high specificity and low toxicity. But 
these in silico methods must be followed by validating 
experiments for defining activity, selectivity, toxicity and 
mechanism of action of chemically synthesized versions of the 
identified drug entities from natural resources. [74]. 
Future Prospects 
Tribal communities having distinct culture, values and 
practices hold on to their traditional knowledge which is 
transmitted only to people belonging to their clan. The 
specialized traditional knowledge consists of medicinal plant 
remedies and community healthcare. Deriving indigenous 
knowledge from these communities of their traditions, and then 
exploring for medicinal plant diversity in a systematic manner, 
benefits through their commercial exploitation in future. Hence 
documentation and developing a database on existing 
knowledge is very important to ensure its proper use. Although 
Indian government has made effort to protect the biodiversity 
and counter the problem of biopiracy by enacting legislations 
like the Biological Diversity Act 2002 and Patents Amendment 
Act 2005, a wide range of approaches are required for 
sustainable and effective protection of tribal traditional 
knowledge. It is also very important to carry out future 
investigations on the diversity of the medicinal plants as well as 
its scientific function with respect to the tribal communities and 
its diversity-function relationship. Studies on bioactive 
rhizospheric microflora associated with rhizosphere of 
medicinal plants of the tribal community has not been 
considered as research target, therefore, evaluation of the 
differences of rhizo-bacterial diversity and the bioactive 
component of selected medicinal plants among different 
habitats is also important and will lead to exploration of the 
relationship between microorganism diversity and the quality of 
genuine authentic crude drug. Hence, these plants should be 
investigated for novel antimicrobial compounds that lead to 
rational drug design. Conventionally drug development was 
carried out by a hit and miss approach. But with the advent of 
computational approach or in-silico approach of drug 
designing, it has led to discovery of various novel chemical 
entities with promising activity against a particular biological 
target. The integration of bioinformatics and wet lab will lead to 
formulation of more effective natural therapeutic products from 
the medicinal plants of the tribal community and will be helpful 
for sustainable management. 
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